Maria Bjurberg

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 394 citations

Medicine, Oncology, Pharmacotherapy +13

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Ignace Vergote, Antonio González‐Martín, Keiichi Fujiwara et al. · New England Journal of Medicine · 2024 · 159 citations · Full text

Medicine, Gynecology, Oncology +16

Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study

Karin Stålberg, Maria Bjurberg, Christer Borgfeldt et al. · Acta Oncologica · 2019 · 98 citations · Full text

Medicine, Gynecology, Oncology +16

Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients

Mona Ridderheim, Maria Bjurberg, Anita Gustavsson · Supportive Care in Cancer · 2003 · 73 citations

Medicine, Dermatology, Oncology +14

Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study

Per Rosenberg, Preben Kjølhede, Christian Staf et al. · Acta Oncologica · 2017 · 72 citations · Full text

Medicine, Gynecology, Oncology +17